FDA Approves the first Actemra biosimilar- called tocilizumab-bavi (Tofidence) or BIIB800 (during development). This IV FORMULATION is approved for use in active RA, polyarticular JIA and systemic JIA. https://t.co/AJD4uOS9hz https://t.co/8bmyTUWyFs https://t.co/6IYjk0XUJq https://t.co/OfjdvJZciB
Links:
FDA Approves Biogen’s TOFIDENCE™ (tocilizumab-bavi), a Biosimilar Referencing A…
https://bit.ly/3TzVACp
FDA Approves First Tocilizumab Biosimilar for US Arthritis Patients
https://bit.ly/3tsZQsM
t.co / Twitter
https://bit.ly/3NzIRvy
Dec-22-2023
